Genetic polymorphisms associated with the development of arrhythmic type of cardiovascular events
Open Access
- 14 September 2022
- journal article
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 27 (3S), 5069
- https://doi.org/10.15829/1560-4071-2022-5069
Abstract
The review analyzes the global agenda on mutational status of genes associated with adverse cardiovascular events of arrhythmic type. Whole exome sequencing will identify a risk group for the likelihood of early or delayed cardiovascular events of arrhythmic type, especially among patients receiving anticancer therapy with cardiotoxic drugs. The dedicated up-to-date panel of genetic polymorphisms will provide an opportunity to optimize management of patients, based on not only clinical, paraclinical and anamnestic data.Keywords
This publication has 46 references indexed in Scilit:
- The importance of being selectiveHeart Rhythm, 2019
- Association between the polymorphisms of CALM1 gene and osteoarthritis risk: a meta-analysis based on observational studiesBioscience Reports, 2018
- A unique triadin exon deletion causing a null phenotypeHeartRhythm Case Reports, 2018
- Inhibition of Voltage-Gated K+ Channel Kv1.5 by Antiarrhythmic DrugsBiochemistry, 2018
- Voltage-gated sodium channel β subunits: The power outside the pore in brain development and diseaseNeuropharmacology, 2018
- Diagnostic Criteria, Genetics, and Molecular Basis of Arrhythmogenic CardiomyopathyHeart Failure Clinics, 2018
- Carvedilol for Prevention of Chemotherapy-Related CardiotoxicityJournal of Invasive Cardiology, 2018
- Expression Atlas: gene and protein expression across multiple studies and organismsNucleic Acids Research, 2017
- ACE2, CALM3 and TNNI3K polymorphisms as potential disease modifiers in hypertrophic and dilated cardiomyopathiesMolecular and Cellular Biochemistry, 2017
- Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patientsBreast Cancer Research and Treatment, 2015